login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VENTYX BIOSCIENCES INC (VTYX) Stock News
USA
- NASDAQ:VTYX -
US92332V1070
-
Common Stock
8.378
USD
+1.01 (+13.68%)
Last: 10/30/2025, 1:21:05 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VTYX Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Chartmill
- Mentions:
ALEC
GNLN
BYND
BATL
...
Which stocks have an unusual volume on Friday?
7 days ago - By: Chartmill
- Mentions:
SLE
AMBI
BIOA
ITGR
...
Here are the top movers in Thursday's session.
7 days ago - By: Benzinga
- Mentions:
STM
AAL
SMPL
GTX
...
Crude Oil Surges 5%; American Airlines Shares Jump After Q3 Results
7 days ago - By: Chartmill
- Mentions:
F
TSLA
BYND
RGTI
...
Most active stocks in Thursday's session
7 days ago - By: Benzinga
Ventyx Stock Is Rallying Thursday: What's Driving The Surge?
7 days ago - By: Chartmill
- Mentions:
CLB
SLE
AMBI
BIOA
...
Which stocks are moving on Thursday?
7 days ago - By: Chartmill
- Mentions:
CLB
SSL
AMBI
BIOA
...
These stocks are gapping in today's session
7 days ago - By: Chartmill
- Mentions:
SLE
MOH
BIOA
BYND
...
Wondering what's happening in today's pre-market session?
7 days ago - By: Stocktwits
Ventyx Biosciences Stock: Retail Buzz Spikes After Phase 2 Win In Obesity And Heart Risk Study
8 days ago - By: Chartmill
- Mentions:
CLB
SLE
MOH
MHO
...
Which stocks are moving after the closing bell on Wednesday?
8 days ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
8 days ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
2 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
3 months ago - By: The Motley Fool
Ventyx (VTYX) Q2 Net Loss Drops 16%
5 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
6 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
7 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
8 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
9 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
10 months ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio
a year ago - By: Bragar Eagel & Squire
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
a year ago - By: Ventyx Biosciences, Inc.
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
Please enable JavaScript to continue using this application.